DNA Microarray Market Expansion 2024-2033

Market Size –
The DNA microarray market size has grown rapidly in recent years. It will grow from $3.02 billion in 2023 to $3.38 billion in 2024 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to pharmacogenomics, healthcare infrastructure development, collaborations and partnerships, cost reduction, and public awareness and education.

The DNA microarray market size is expected to see rapid growth in the next few years. It will grow to $5.34 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to growth in personalized medicine, the emergence of comparative genomic hybridization (CGH), expansion in agricultural genomics, regulatory approvals, and standards, and the rising prevalence of chronic diseases. Major trends in the forecast period include advancements in genomic research, increased funding for genomic studies, technological innovations, integration with other technologies, and technological advancements.

Order your report now for swift delivery @
https://thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Scope Of DNA Microarray Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

DNA Microarray Market Overview

Market Drivers –
The rapid adoption of personalized medicine is expected to propel the growth of the DNA microarray market. Personalized medicine tailors medical treatment to the individual characteristics of each patient, considering genetic, environmental, and lifestyle factors to optimize therapeutic efficacy and outcomes. Personalized medicine has emerged due to the rapid growth of ‘omics’ technology, data integration, genetics, and an awareness of the significance of tailored patient-specific medications and preventive actions. DNA microarrays enable personalized medicine by analyzing gene expression patterns, allowing tailored treatment plans based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rapid adoption of personalized medicine is driving the DNA microarray market.

Market Trends –
Major companies operating in the DNA microarray market are focusing on developing advanced technology that provides a two-day turnaround time to gain a competitive edge. Microarray analysis offers a two-day turnaround time, ensuring swift and efficient results. This rapid processing accelerates research and clinical decision-making. For instance, in August 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced the Applied Biosystems CytoScan HD Accel array, a new chromosomal microarray aimed at enhancing productivity, efficiency, and profitability in cytogenetic research labs with a leading two-day turnaround time. The CytoScan HD Accel array performs whole-genome analysis with improved coverage in over 5,000 key genomic regions, delivering insights on chromosomal variants for diverse applications in prenatal, postnatal, and oncology research.

The DNA microarray market covered in this report is segmented –

1) By Type: Complementary DNA Microarrays, OligonucleotideÃ‚Â DNA Microarrays, Other Types
2) By Application: Gene Expression Analysis, Genotyping, Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies, Diagnostic Centers, Hospitals And Clinics, Academic And Research Institute, Other End-users

Get an inside scoop of the dna microarray market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp

Regional Insights –
North America was the largest region in the DNA microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –

Major companies operating in the DNA microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMÃ©rieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

Table of Contents
1. Executive Summary
2. DNA Microarray Market Characteristics
3. DNA Microarray Market Trends And Strategies
4. DNA Microarray Market – Macro Economic Scenario
5. Global DNA Microarray Market Size and Growth
.
.
.
31. DNA Microarray Market Other Major And Innovative Companies
32. Global DNA Microarray Market Competitive Benchmarking
33. Global DNA Microarray Market Competitive Dashboard
34. Key Mergers And Acquisitions In The DNA Microarray Market
35. DNA Microarray Market Future Outlook and Potential Analysis
36.Appendix